From February 2014 investor presentation: Low cost proof of...

From February 2014 investor presentation:

Low cost proof of concept development progressing for two new topical
products:
– Non-melanoma skin cancer (NMSC) therapeutic
– Anti-fungal therapeutic
– Both products address unmet need in large (billion dollar+) markets
– New intellectual property developed and patent applications currently being
filed
– Topical pain relief product also in formulation development

Any updates on these - oh wait can't ask till AGM!! - does anyone know or have any links to where these are at?. Would like to see what is happening with these as these could create additional income streams (but depends on when they come on line - if at all).